A thorough examination of the current literature on EGFR and cancer prognosis highlights a consistent correlation between elevated EGFR levels and unfavorable patient outcomes across various cancer types, including head and neck, ovarian, cervical, bladder, and esophageal cancer [51]. This evidence concerns the gene EGFR and esophageal cancer.